Glycemic control in patients with insulinoma

被引：33
作者：
Matej, Agata [1 ]
Bujwid, Hanna [2 ]
Wronski, Jakub [3 ]
机构：
[1] Prof W Orlowski Hosp, Warsaw, Poland
[2] Wolski Hosp, Warsaw, Poland
[3] Warsaw Med Univ, Dept Disaster Med, Warsaw, Poland
来源：
HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM | 2016年 / 15卷 / 04期
关键词：
Insulinoma; Glycemic control; Hypoglycemia; Hyperinsulinism; Pharmacotherapy; PANCREATIC NEUROENDOCRINE TUMORS; ENETS CONSENSUS GUIDELINES; MALIGNANT INSULINOMA; METASTATIC INSULINOMA; MEDICAL-TREATMENT; MANAGEMENT; HYPOGLYCEMIA; EVEROLIMUS; DIAZOXIDE; THERAPY;
D O I：
10.14310/horm.2002.1706
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Insulinoma is the most common neuroendocrine tumor of the pancreas. Surgical management of insulinomas is considered to be the only curative method. However, effective glycemic control preoperatively and in unresectable insulinomas remains a significant issue. Hyperinsulinism, occurring as a result of the hormone-secreting tumor, leads to life-threatening hypoglycemia episodes which require urgent medical treatment. This article discusses current management of hypoglycemia in insulinoma patients, including: education and lifestyle modifications, pharmacotherapy (diazoxide, somatostatin analogs, mTOR inhibitor - everolimus), cytoreductive methods and continuous glucose monitoring systems.
引用
收藏
页码：489 / 499
页数：11
相关论文
共 50 条
  • [21] Malignant insulinoma: Report of 6 patients and literature review
    Shao, Yi
    Qu, Yu-Qing
    Wang, Xian-Ling
    Song, Zhi-Gang
    Guo, Qing-Hua
    Dou, Jing-Tao
    Ba, Jian-Ming
    Lu, Zhao-Hui
    Mu, Yi-Ming
    NEUROENDOCRINOLOGY LETTERS, 2016, 37 (03) : 189 - 192
  • [22] Peptide receptor radionuclide therapy as a tool for the treatment of severe hypoglycemia in patients with primary inoperable insulinoma
    Opalinska, Marta
    Sowa-Staszczak, Anna
    Al Maraih, Ibraheem
    Gilis-Januszewska, Aleksandra
    Hubalewska-Dydejczyk, Alicja
    BIO-ALGORITHMS AND MED-SYSTEMS, 2021, 17 (04) : 221 - 226
  • [23] Should everolimus be stopped after radiological progression in metastatic insulinoma? A "cons" point of view
    Tovazzi, Valeria
    Ferrari, Vittorio D.
    Dalla Volta, Alberto
    Consoli, Francesca
    Amoroso, Vito
    Berruti, Alfredo
    ENDOCRINE, 2020, 69 (03) : 481 - 484
  • [24] Pancreatic insulinoma causing hypoglycemic episodes
    Mahdi, Moaffaq
    Almehman, Bassel
    Nassan, Safi
    Binyahib, Soliman
    JOURNAL OF PEDIATRIC SURGERY CASE REPORTS, 2020, 57
  • [25] Metastatic insulinoma presenting after bariatric surgery in a patient diagnosed with MEN1
    Poku, Caroline
    Amjed, Hafsa
    Kazi, Fatima
    Samarasinghe, Shanika
    CLINICAL CASE REPORTS, 2022, 10 (02):
  • [26] CGM for insulinoma screening: a prospective and observational case-control study
    Ma, Jingyuan
    Huang, Xinyu
    Zhao, Jungong
    Lu, Jingyi
    Lu, Wei
    Bao, Yuqian
    Zhou, Jian
    Han, Junfeng
    ENDOCRINE-RELATED CANCER, 2021, 28 (05) : 291 - 300
  • [27] A severe but reversible reduction in insulin sensitivity is observed in patients with insulinoma
    Furnica, Raluca Maria
    Istasse, Laure
    Maiter, Dominique
    ANNALES D ENDOCRINOLOGIE, 2018, 79 (01) : 30 - 36
  • [28] Phenomenon of hypoglycemia unawareness in patients with insulinoma - single center experience
    Nosakova, Lenka
    Banovcin, Peter
    Duricek, Martin
    Uhrik, Peter
    Bozikova, Janka
    Demeter, Michal
    Hyrdel, Rudol
    NEUROENDOCRINOLOGY LETTERS, 2021, 42 (08) : 522 - 527
  • [29] Optimal Glycemic Control in Hospitalized Patients
    Meadows, Renee Y.
    HOSPITAL MEDICINE CLINICS, 2015, 4 (04) : 471 - 488
  • [30] Perioperative glycemic control with a computerized algorithm versus conventional glycemic control
    M Punke
    S Bruhn
    M Goepfert
    S Kluge
    H Reichenspurner
    A Goetz
    D Reuter
    Critical Care, 16 (Suppl 1):
12345